Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members
This article was originally published in The Tan Sheet
Executive Summary
A "significant fraction" of current FDA advisory committee members' eligibility to vote and participate in meetings would be affected by a revised conflict of interest policy, FDA said